Tom Murphy

AP Business Writer
Latest in Supply Chain
Financial Storytelling in the Age of AI
Sponsored
Financial Storytelling in the Age of AI
October 1, 2026
Green and blue fuel pump nozzles labeled Petrol and Diesel at a gas station dispenser
G7 Nations Agree to Release 100 Million Barrels of Oil, Including Diesel
October 2, 2026
Female technician in safety glasses working on electrical panel with orange and blue wiring in industrial facility
OEM v. Third-Party: Why Selecting the Right Service Provider Matters
October 1, 2026
Precision drilling machine performing circuit board assembly with blue-toned industrial equipment
The Semiconductor Industry Is Scaling Fast. Can Its Supply Chain Keep Up?
October 1, 2026
Related Stories
I Stock 140468454 5835a8ffaf08b
Supply Chain
Gas Prices Second-Lowest in 8 Years
Law enforcement and protesters clash near the site of the Dakota Access pipeline on Sunday, Nov. 20, 2016, in Cannon Ball, N.D. The clash came as protesters sought to push past a bridge on a state highway that had been blockaded since late October, according to the Morton County Sheriff's Office.
Supply Chain
Injured Pipeline Protester May Lose Arm
Jobs 58359e7935f4e
Supply Chain
Durable Goods Orders Up 4.8% in Oct
Financial Storytelling in the Age of AI
Sponsor Content
Financial Storytelling in the Age of AI
More from Tom Murphy
The Hidden Costs of Standing Still
Sponsored
The Hidden Costs of Standing Still
Why delaying ERP modernization is riskier than you think.
October 1, 2026
Ap24283715738972
Operations
Expect Employers to Get More Picky About Who You See for Care
Large companies expect costs to jump by the highest growth rate in a decade.
October 14, 2024
A Rite Aid sign is displayed on the facade of a store in Pittsburgh, Jan. 23, 2023. Rite Aid has been banned from using facial recognition technology for five years over allegations that a surveillance system it used incorrectly identified potential shoplifters, especially Black, Latino, Asian or female shoppers. The deal announced late Tuesday, Dec. 19, settles Federal Trade Commission charges that the struggling drugstore chain didn’t do enough to prevent harm to its customers and implement “reasonable procedures,” the government agency said.
Artificial Intelligence
Rite Aid Banned from Using Facial Recognition
The retailer faced allegations that its surveillance system was used incorrectly to identify potential shoplifters.
December 21, 2023
A man walks by Pfizer headquarters, Friday, Feb. 5, 2021 in New York.
Operations
Pfizer's COVID-19 Sales Forecast Falls About $5 Billion Short
The switch from selling COVID-19 drugs on the market rather than to governments continues to sting the drugmaker.
December 13, 2023
This Sept. 21, 2021 file photo shows vials of the Pfizer and Moderna COVID-19 vaccines in Jackson, Miss.
Product Development
Moderna Sues Pfizer Over COVID-19 Vaccine Patents
The company is accusing its main competitors of copying proprietary technology.
August 26, 2022
This image provided by Pfizer shows its COVID-19 pills. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks.
Product Development
Pfizer, U.S. Ink $5.29B Deal for Possible COVID-19 Treatment
The price for Pfizer’s potential treatment amounts to about $529 per course.
November 18, 2021
This Oct. 16, 2012 file photo shows the Johnson & Johnson logo on a package of Band-Aids, in St. Petersburg, Fla. Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business.
Operations
Johnson & Johnson to Split into 2 Companies
The company is the world’s biggest maker of health care products.
November 12, 2021
In this Tuesday, Oct. 25, 2016, file photo, Joaquin Duato attends the fourth annual Save the Children Illumination Gala at The Plaza Hotel in New York. Johnson & Johnson said late Thursday, Aug. 19, 2021, will replace Chairman and CEO Alex Gorsky with Duato starting next year.
Operations
J&J CEO to Step Down
He's being replaced with another veteran company executive.
August 20, 2021
This combination of file photos from left shows Warren Buffett, chairman and CEO of Berkshire Hathaway, on Sept. 19, 2017, in New York, Jeff Bezos, CEO of Amazon.com, on Sept. 24, 2013, in Seattle and JP Morgan Chase Chairman and CEO Jamie Dimon on July 12, 2013, in New York. A health care venture created in 2018 by the three corporate giants to attack soaring care costs will shutter only a couple years after launching. A company spokeswoman said Monday, Jan. 4, 2021, that Haven will end operations in February.
Operations
Amazon Bid to Address Soaring Health Costs is Over
Haven is quietly dissolving less than three years after it was formed.
January 4, 2021
This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients.
Product Development
Lilly Stays Confident in Possible COVID Drug After Setback
The drugmaker maintains that its drug may stop COVID from developing in other patients.
October 27, 2020
A patient during a telemedicine video conference with Dr. Deborah Mulligan, Jan. 14, 2019, in Brooklyn.
Software
Outbreak Prompts Push to Telemedicine
Americans have been slow to embrace virtual care, but that may be changing.
March 23, 2020
Oxy
Operations
Purdue Begins Bankruptcy Journey
Initial proceedings begin today for the OxyContin maker that filed for bankruptcy and negotiated a potential multi-billion dollar settlement.
September 17, 2019
This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will introduce a version of the diabetes treatment called Insulin Lispro with a list price 50 percent lower than its current rate, about $275 per vial.
Product Development
Eli Lilly to Sell Cheaper Insulin
The initial list price will be 50 percent lower than Humalog's current rate of about $275 per vial.
March 5, 2019
In this June 1, 2017, file photo, a sign stands on the campus of the Aetna headquarters in Hartford, Conn. Some major health insurers plan to take a little sting out of prescription drug prices by giving customers rebates at the pharmacy counter, and they could spark a trend. Aetna and UnitedHealthcare both say they will begin passing rebates they get from drugmakers along to some of their customers starting next year.
Operations
Drugmaker Rebates May Reach Consumers
Aetna and UnitedHealthcare both say they will begin passing rebates they get from drugmakers along to some customers starting next year.
April 11, 2018
In this June 30, 2011 file photo, a sign from of the Eli Lilly and Co corporate headquarters is pictured in Indianapolis. Eli Lilly will slash its global workforce by nearly 9 percent as the drugmaker closes some research sites and pushes to trim fixed costs. The Indianapolis company said Thursday, Sept. 7, 2017, it will cut about 3,500 positions, mostly through a voluntary retirement program in the United States. The insulin maker employed 41,240 people worldwide at the end of June.
Operations
Eli Lilly Cuts 3,500 Jobs
The company hopes to streamline by closing some facilities and moving production.
September 8, 2017